Abstract
The Frontal Fibrosing Alopecia Severity Score (FFASS) was described to classify frontal fibrosing alopecia (FFA) patients. Its prospective use can help us to understand better the relationship between inflammation and hairline recession. We conducted a three-year prospective study. All patients started the same treatment in the first visit (oral dutasteride 0.5 mg 3 times a week, topical clobetasol twice weekly and triamcinolone injections 4-8 mg/mL). Patients were assessed with the FFASS every 6 months.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
